Kenko International appoints new president and CEO of U.S. subsidiary

Alissa Marrapodi

Alissa Marrapodi is Industry Insights Contributor, Custom Content Editor, MJH Life Sciences.

The Board of Directors of Kenko International, Inc. announced the appointment of Kevin Johnson to president and CEO of its U.S.-subsidiary.

The Board of Directors of Kenko International, Inc. (Tokyo, Japan) announced the appointment of Kevin Johnson to president and CEO of the U.S.-subsidiary of Kenko International, Inc. (Los Angeles, CA). Johnson, who was previously the senior vice president of Kenko International, Inc., will play an instrumental role in generating new business and managing key accounts.

“I am very pleased to announce that we have appointed Mr. Kevin Johnson to the post of President and CEO,” said Yoshihiro Kawabata, president of Kenko Holding Company, Inc. and director of the board of Kenko International, Inc., in a press release. “Johnson’s expertise in sales and management will help us continue to prosper in this chemical ingredient marketplace that we have been serving globally since 1965. His efforts will help expand our operation in the marketing of raw materials for nutraceuticals, pharmaceuticals, cosmetics, and food chemical ingredients in the United States.”